Awareness and Knowledge of Pre-exposure Prophylaxis Among Sexual and Gender Minority Adolescents Assigned Male at Birth in the United States

Sexual and gender minority (SGM) adolescents assigned male at birth are at increased risk for HIV infection. Pre-exposure prophylaxis (PrEP) is a daily pill taken to prevent HIV, which the United States Food and Drug Administration approved for minors under age 18 years weighing at least 77.5 lb in...

Full description

Saved in:
Bibliographic Details
Published inArchives of sexual behavior Vol. 50; no. 4; pp. 1701 - 1711
Main Authors Matson, Margaret, Nery-Hurwit, Mara, Crosby, Shariell, Greene, George J., Macapagal, Kathryn
Format Journal Article
LanguageEnglish
Published New York Springer US 01.05.2021
Springer Nature B.V
Subjects
Adolescent
Adult
Behavioral Science and Psychology
Disease prevention
FDA approval
Gender Identity
Health Knowledge, Attitudes, Practice
HIV
HIV Infections - prevention & control
Homosexuality, Male
Human immunodeficiency virus
Humans
Male
Mens health
Original Paper
Pre-Exposure Prophylaxis
Psychology
Public Health
Sexual and Gender Minorities
Sexual Behavior
Social Sciences
Teenagers
United States
United States
United States > US
Sexual and gender minority adolescents
Transgender
Sexual orientation
HIV
Pre-exposure prophylaxis
Online AccessGet full text

Cover

More Information
Summary:Sexual and gender minority (SGM) adolescents assigned male at birth are at increased risk for HIV infection. Pre-exposure prophylaxis (PrEP) is a daily pill taken to prevent HIV, which the United States Food and Drug Administration approved for minors under age 18 years weighing at least 77.5 lb in 2018. A lack of awareness and knowledge of PrEP are barriers to uptake among adults and adolescents, but SGM adolescents’ awareness and knowledge about PrEP remain underexplored and no studies have assessed SGM adolescents’ informational needs. We collected data on 59 SGM adolescents’ (ages 14–18 years) awareness, knowledge, and questions about PrEP in an online survey and six online focus groups. Although a majority of SGM adolescents (83.1%) were aware of PrEP before the study, many wanted more information about side effects and how to navigate potential barriers to PrEP initiation. Findings can inform public health efforts to promote PrEP knowledge and uptake among SGM adolescents.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0004-0002
1573-2800
DOI:10.1007/s10508-020-01904-7